Table 1.
Baseline data of patient characteristics in three groups.
| End-stage PDR | Normals (n = 151) | ||
|---|---|---|---|
| Yes (n = 153) | No (n = 123) | ||
| Male (n[%]) | 62 (40.523)⋇ | 48 (39.024)⋇ | 63 (41.722) |
| Age, years# | 52.719 ± 6.661⋇§ | 57.626 ± 8.006* | 53.136 ± 7.342 |
| PAI-1, pmol/dL# | 7.394 ± 2.084∗§ | 6.216 ± 0.989* | 1.952 ± 0.276 |
| 95%CI | 7.062–7.727 | 6.040–6.393 | 1.851–2.053 |
| Family history of DM (n[%]) | 13 (8.497)§ | 36 (29.268) | — |
| History of hypertension (n[%]) | 89 (58.170)§ | 75 (60.976) | — |
| Smoking (n[%]) | |||
| Active | 61 (39.869) | 46 (37.398) | — |
| Passive | 153 (100.000) | 123 (100.000) | — |
| Duration of DM# | 12.496 ± 6.173§ | 9.954 ± 4.441 | — |
| FBG, mmol/L# | 7.125 ± 1.987§ | 6.512 ± 2.157 | — |
| PBG, mmol/L# | 9.919 ± 3.401 | 9.226 ± 3.786 | — |
| SBP, mmHg# | 136.272 ± 11.114§ | 131.952 ± 14.719 | — |
| DBP, mmHg# | 84.771 ± 6.985§ | 82.602 ± 9.373 | — |
| TC, mmol/L# | 5.161 ± 0.784 | 5.222 ± 1.101 | — |
| TG, mmol/L# | 2.115 ± 1.509 | 1.854 ± 1.628 | — |
| CREA, umol/L# | 82.971 ± 52.230§ | 70.085 ± 33.491 | — |
| BUN, mmol/L# | 6.890 ± 2.630 | 6.345 ± 2.242 | — |
| PAI-1, pmol/dL# | 7.394 ± 2.084§ | 6.216 ± 0.989 | — |
| WBC, 109/L# | 6.709 ± 1.606 | 6.513 ± 1.953 | — |
| RBC, 1012/L# | 4.350 ± 0.396 | 4.347 ± 0.563 | — |
| HGB, g/L# | 54.831 ± 65.599 | 130.452 ± 18.130 | — |
| Lymphocyte counts, 109/L# | 7.643 ± 2.164§ | 1.784 ± 0.555 | — |
| MPV, # | 9.871 ± 0.792§ | 10.192 ± 0.971 | — |
∗ P < 0.01 versus normals; § P < 0.05 versus no end-stage PDR; ⋇ P > 0.05 versus normal.
#Continuous variables are presented as the mean with the standard deviation.